SCHEMBL168931

SCHEMBL168931

Cc1ccc(Br)cc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747323 0.97 CYP3A4 (0.50)
SCHEMBL29391325 0.79
SCHEMBL264070 0.79
SCHEMBL89325 0.78
Magnesium SCHEMBL31567264 0.77 ALDH1A1 (0.42)
Fluoride SCHEMBL27598987 0.77 ALDH1A1 (0.42)
Fluoride SCHEMBL27279145 0.77 ALDH1A1 (0.42)
SCHEMBL1313272 0.76 CYP3A4 (0.54)
Water SCHEMBL28511306 0.76 CYP3A4 (0.54)
SCHEMBL40336 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 591 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692101-B1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES ALFA INSTR S R L (IT) 2022-01-12 EP claimed
EP-3692101-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES Alfa Instruments S.r.l. (IT) 2020-08-12 EP claimed
WO-2019068935-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES ALFA INSTRUMENTS S.R.L. (IT) 2019-04-11 WO claimed
US-7998623-B2 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2011-08-16 US claimed
CN-101712603-A Method for preparing halogenated methyl-benzaldehyde by Grignard reaction UNIV JIANGSU POLYTECHNIC 2010-05-26 CN claimed
US-7473683-B2 Nonpolar thymidine analogs THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2009-01-06 US claimed
US-20070065360-A1 Nonpolar thymidine analogs NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-03-22 US claimed
US-20060078792-A1 Electrolyte for lithium ion secondary battery and lithium ion secondary battery including the same SAMSUNG SDI CO., LTD. (KR) 2006-04-13 US claimed
US-20260070932-A1 INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF ANNEXON INC (US) 2026-03-12 US disclosed
EP-4103557-B1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2026-02-18 EP disclosed
US-12522619-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2026-01-13 US disclosed
US-12516065-B2 Tertiary alcohols as PI3K-γ inhibitors INCYTE CORPORATION (US) 2026-01-06 US disclosed
US-12509474-B2 Inhibitors of complement factors and uses thereof ANNEXON, INC. (US) 2025-12-30 US disclosed
US-20250388553-A1 AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS INCYTE CORP (US) 2025-12-25 US disclosed
US-4024283-A HYPOLIPIDEMIC AGENTS SANDOZ, INC. (US) 1977-05-17 US disclosed
US-4011344-A HYPOLIPIDEMIC AGENTS SANDOZ, INC. (US) 1977-03-08 US disclosed
US-3996286-A HYPOLIPIDEMIC AGENTS, HYPOCHOLESTEROLEMICS SANDOZ, INC. (US) 1976-12-07 US disclosed
US-3978132-A HYPOLIPIDEMIC SANDOZ, INC. (US) 1976-08-31 US disclosed
US-3970601-A COATINGS BAYER AKTIENGESELLSCHAFT (DT) 1976-07-20 US disclosed
US-3962320-A HYPOLIPIDEMIC AGENTS SANDOZ, INC. (US) 1976-06-08 US disclosed